Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pincer Biotech ApS
APS
In liquidation
CVR 40497978
Skt. Clemens Stræde 7
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik · NACE 721900
Est. 2019
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2022
DKK -407K
+83% vs 2021
EBITDA margin
117.1%
-114% vs 2021
Equity ratio
1.4%
Financial strength
Net profit 2022
DKK -409K
-62% vs 2021
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
Key figures
Annual report 2022
Revenue
DKK -407K
+83%
EBITDA
DKK -476K
-114%
Net profit
DKK -409K
-62%
Total assets
DKK 2M
-13%
Equity
DKK 27K
-94%
Employees
—
—
Company information
Legal name
Pincer Biotech ApS
CVR number
40497978
Legal form
Anpartsselskab
NACE code
721900 · Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Founded
6. maj 2019
Share capital
DKK 64.328
Employees
—
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Skt. Clemens Stræde 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Companies in Aarhus
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
0M
2022
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
0M
2022
Income statement
DKK thousands
Item
2019
2020
2021
2022
Revenue
-23
-44
-222
-407
Staff expenses
-2
-3
-1
-69
EBITDA
-25
-46
-223
-476
Depreciation & amort.
-0
-0
-0
-0
EBIT
-25
-46
-223
-476
Net financials
-0
-0
-90
-114
Profit before tax
-25
-47
-312
-590
Tax
-5
-20
-59
-180
Net profit
-20
-27
-253
-409
Balance sheet
DKK thousands
Item
2019
2020
2021
2022
Total assets
173
948
2.314
2.024
Equity
30
690
437
27
Long-term debt
100
200
1.865
1.966
Short-term debt
24
29
12
30
Total debt
124
229
1.877
1.996
Financial ratios
5-year trend
EBITDA margin
-47620800.0%
This company
15.8%
Market median
-301397568% vs market
2019
2022
Equity ratio
1.4%
This company
38.2%
Market median
-96% vs market
2019
2022
Return on equity
-1493.1%
This company
18.4%
Market median
-8215% vs market
2019
2022
Net profit margin
-40932400.0%
This company
8.1%
Market median
-505338372% vs market
2019
2022
Asset turnover
-0.20×
This company
1.12×
Market median
-118% vs market
2019
2022
Debt / equity
72.82×
This company
0.62×
Market median
-11645% vs market
2019
2022
Annual reports & filings
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-05-06 – 2019-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
JB
Jakob Brix Kvols
Unofficial title
Unofficial title
2024
—
—
CD
Charlotte Dyring
Chief Executive Officer
Chief Executive Officer
2022
—
—
CH
Claus Hansen
Management
Management
2019
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
LOST HOLDING ApS
Company
33.3%
33.3%
2019
CH MEDINVEST ApS
Company
33.3%
33.3%
2019
POUL CARSTENSEN HOLDING ApS
Company
5.0%
5.0%
2020
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Pincer Biotech ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Jakob Brix Kvols
Unofficial title
0 companies
Charlotte Dyring
Chief Executive Officer
0 companies
Claus Hansen
Management
0 companies